Exane Derivatives’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,109	Closed	-$811K	–	997
2022 Q1	$811K	Buy	+3,109	New	+$738K	0.23%	117
2021 Q4	–	Sell	-1,024	Closed	-$186K	–	1051
2021 Q3	$186K	Buy	1,024 +70	+7%	+$13.7K	0.05%	411
2021 Q2	$189K	Buy	954 +223	+31%	+$46.6K	0.04%	415
2021 Q1	$157K	Buy	+731	New	+$161K	0.05%	334
2020 Q4	–	Sell	-1,916	Closed	-$521K	–	875
2020 Q3	$521K	Buy	1,916 +300	+19%	+$82.8K	0.17%	126
2020 Q2	$469K	Sell	1,616 -821	-34%	-$223K	0.14%	139
2020 Q1	$580K	Buy	2,437 +2,387	+4,774%	+$548K	0.2%	112
2019 Q4	$11.7K	Sell	50 -1,066	-96%	-$216K	﹤0.01%	411
2019 Q3	$189K	Hold	1,116	–	–	0.04%	262
2019 Q2	$205K	Buy	1,116 +1,069	+2,274%	+$187K	0.04%	263
2019 Q1	$8.64K	Sell	47 -754	-94%	-$139K	﹤0.01%	397
2018 Q4	$133K	Hold	801	–	–	0.03%	292
2018 Q3	$154K	Buy	801 +92	+13%	+$16.4K	0.03%	271
2018 Q2	$119K	Hold	709	–	–	0.03%	312
2018 Q1	$113K	Buy	709 +708	+70,800%	+$116K	0.03%	286
2017 Q4	$150	Hold	1	–	–	﹤0.01%	527
2017 Q3	$152	Hold	1	–	–	﹤0.01%	496
2017 Q2	$129	Sell	1 -152	-99%	-$18.3K	﹤0.01%	557
2017 Q1	$16.7K	Sell	153 -1,368	-90%	-$120K	﹤0.01%	335
2016 Q4	$112K	Buy	1,521 +932	+158%	+$75.8K	0.03%	240
2016 Q3	$51.4K	Sell	589 -3,754	-86%	-$355K	0.01%	299
2016 Q2	$374K	Buy	4,343 +359	+9%	+$31K	0.06%	159
2016 Q1	$317K	Buy	3,984 +3,299	+482%	+$298K	0.05%	166
2015 Q4	$86.2K	Buy	+685	New	+$82.7K	0.01%	225
2015 Q2	–	Sell	-1,582	Closed	-$187K	–	572
2015 Q1	$187K	Sell	1,582 -197,406	-99%	-$23.7M	0.02%	212
2014 Q4	$23.6M	Buy	+198,988	New	+$22.4M	3.58%	2